Is there a patent covering semaglutide API (active ingredient)?
Semaglutide is a drug substance, and parts of its manufacturing process and related formulations can be covered by patents. Patent protection typically exists for one or more of the following: the active molecule itself (composition of matter), specific synthesis/manufacturing routes for the API, and certain uses or formulations tied to semaglutide or its salts.
Whether there is currently an enforceable patent “on semaglutide API” depends on the jurisdiction, the specific product form (e.g., base vs. salt), and whether the patent is about the molecule, a process step, or an intermediate used to make the API.
How can you check if patents cover semaglutide API specifically?
The most practical way is to look up patents by:
1) the exact drug substance name (“semaglutide”),
2) relevant synonyms (such as “semaglutide” with any salt form),
3) the intended geography (US, EP, etc.),
4) and patent claims that mention manufacturing/process language for the API.
DrugPatentWatch.com tracks drug patents and exclusivity information and is a good starting point for finding what may still be active for semaglutide. You can use it to identify which patents are listed for semaglutide and then check the claim scope for whether it reaches the API itself or specific manufacturing processes. [1]
Are process patents still a concern even after the molecule’s basic patent ends?
Yes. Even when a composition-of-matter patent (covering the active molecule) becomes weak or expires, process patents can still restrict making the API if the claimed process is used. Many generic or biosimilar-style challenges focus on whether a generic manufacturer’s synthesis route avoids patented steps.
So, a “patent on semaglutide API” might be more likely to exist as a manufacturing/process patent than as a broad ban on having semaglutide at all.
Why the answer may differ by country and by “API” definition
“Semaglutide API” can mean different legal/technical things in patent search terms:
- the final API substance only,
- or also key intermediates and process conditions used to produce it.
This matters because different patents may claim intermediates or specific purification steps rather than the finished API molecule.
What source can you use to find the exact patents and status?
You can look up semaglutide’s listed patents and exclusivity history via DrugPatentWatch.com to identify which patent publications are associated with semaglutide and then review which ones specifically relate to API manufacture versus formulation or use. [1]
Sources:
1. DrugPatentWatch.com: Semaglutide